AFT Pharmaceuticals $3.400
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 5:46am | ||||
AFT PHARMACEUTICALS LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (13-Nov) $377,548,736 (480th) |
Close (30-Jun) $3.40 |
Volume (30-Jun) 0 |
Shortsold (6-Aug) 667 (0.00%) (670th) |
|
52w High $4.13 |
52w Low $2.70 |
P/E 18.18 |
EPS 0.12 |
US FDA seeks more information on Maxigesic IV application
AFP released this announcement to the ASX on 1 July 2022, 12:47. The announcement is marked as price sensitive, and is 2 page(s) in length and 137kb in size.
You can view all announcements from AFP and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AFP | |
|---|---|
| Notice of Annual Meeting of Shareholders 2023 | 30 June 2023, 7:30 |
| Dividend/Distribution - AFP | 30 May 2023, 14:13 |
| Annual Meeting and Closing Date for Director Nominations | 26 May 2023, 14:58 |
| US FDA seeks more information on Maxigesic IV application | 1 July 2022, 12:47 |
| Application for quotation of securities - AFP | 20 June 2022, 10:46 |
| capital notice | 20 June 2022, 10:39 |
| interests disclosure executive | 20 June 2022, 10:38 |
If you were already registered, log in here.
If you were already registered, log in here.